70 related articles for article (PubMed ID: 23216958)
1. LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer.
Matsunoki A; Kawakami K; Kotake M; Kaneko M; Kitamura H; Ooi A; Watanabe G; Minamoto T
BMC Cancer; 2012 Dec; 12():574. PubMed ID: 23216958
[TBL] [Abstract][Full Text] [Related]
2. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.
van Bemmel D; Lenz P; Liao LM; Baris D; Sternberg LR; Warner A; Johnson A; Jones M; Kida M; Schwenn M; Schned AR; Silverman DT; Rothman N; Moore LE
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1143-8. PubMed ID: 22539607
[TBL] [Abstract][Full Text] [Related]
3. Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis.
Zhang Y; Ye Y; Shen D; Jiang K; Zhang H; Sun W; Zhang J; Xu F; Cui Z; Wang S
Cancer Sci; 2010 Feb; 101(2):523-9. PubMed ID: 19930159
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers measured in buccal and blood leukocyte DNA as proxies for colon tissue global methylation.
Ashbury JE; Taylor SA; Tse MY; Pang SC; Louw JA; Vanner SJ; King WD
Int J Mol Epidemiol Genet; 2014; 5(2):120-4. PubMed ID: 24959316
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis.
Hur K; Cejas P; Feliu J; Moreno-Rubio J; Burgos E; Boland CR; Goel A
Gut; 2014 Apr; 63(4):635-46. PubMed ID: 23704319
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.
Cao Q; Tian Y; Deng Z; Yang F; Chen E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542332
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Methylation of LINE-1 Transposable Elements: A Search for Cancer Biomarkers.
Ponomaryova AA; Rykova EY; Gervas PA; Cherdyntseva NV; Mamedov IZ; Azhikina TL
Cells; 2020 Sep; 9(9):. PubMed ID: 32887319
[TBL] [Abstract][Full Text] [Related]
8. Methylation-Based Therapies for Colorectal Cancer.
Cervena K; Siskova A; Buchler T; Vodicka P; Vymetalkova V
Cells; 2020 Jun; 9(6):. PubMed ID: 32599894
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis.
Udali S; De Santis D; Ruzzenente A; Moruzzi S; Mazzi F; Beschin G; Tammen SA; Campagnaro T; Pattini P; Olivieri O; Guglielmi A; Choi SW; Friso S
Front Genet; 2017; 8():229. PubMed ID: 29375619
[TBL] [Abstract][Full Text] [Related]
10. Decoupling of DNA methylation and activity of intergenic LINE-1 promoters in colorectal cancer.
Vafadar-Isfahani N; Parr C; McMillan LE; Sanner J; Yeo Z; Saddington S; Peacock O; Cruickshanks HA; Meehan RR; Lund JN; Tufarelli C
Epigenetics; 2017 Jun; 12(6):465-475. PubMed ID: 28300471
[TBL] [Abstract][Full Text] [Related]
11. LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer.
Jiang AC; Buckingham L; Barbanera W; Korang AY; Bishesari F; Melson J
Clin Epigenetics; 2017; 9():25. PubMed ID: 28293326
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations and epigenetic alterations of cancer-associated fibroblasts.
Du H; Che G
Oncol Lett; 2017 Jan; 13(1):3-12. PubMed ID: 28123515
[TBL] [Abstract][Full Text] [Related]
13. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.
Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T
BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637
[TBL] [Abstract][Full Text] [Related]
15. Tumour biomarkers: homeostasis as a novel prognostic indicator.
Falco M; Palma G; Rea D; De Biase D; Scala S; D'Aiuto M; Facchini G; Perdonà S; Barbieri A; Arra C
Open Biol; 2016 Dec; 6(12):. PubMed ID: 27927793
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
[TBL] [Abstract][Full Text] [Related]
17. Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies.
Tang JT; Wang ZH; Fang JY
Onco Targets Ther; 2015; 8():3265-76. PubMed ID: 26604793
[TBL] [Abstract][Full Text] [Related]
18. The Fine LINE: Methylation Drawing the Cancer Landscape.
Miousse IR; Koturbash I
Biomed Res Int; 2015; 2015():131547. PubMed ID: 26448926
[TBL] [Abstract][Full Text] [Related]
19. LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis.
Barchitta M; Quattrocchi A; Maugeri A; Vinciguerra M; Agodi A
PLoS One; 2014; 9(10):e109478. PubMed ID: 25275447
[TBL] [Abstract][Full Text] [Related]
20. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
Inamura K; Yamauchi M; Nishihara R; Lochhead P; Qian ZR; Kuchiba A; Kim SA; Mima K; Sukawa Y; Jung S; Zhang X; Wu K; Cho E; Chan AT; Meyerhardt JA; Harris CC; Fuchs CS; Ogino S
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
